These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 24656003)
1. Expression of erythropoietin and its receptor in kidneys from normal and cyclosporine-treated rats. Lei DM; Piao SG; Jin YS; Jin H; Cui ZH; Jin HF; Jin JZ; Zheng HL; Li JJ; Jiang YJ; Yang CW; Li C Transplant Proc; 2014; 46(2):521-8. PubMed ID: 24656003 [TBL] [Abstract][Full Text] [Related]
2. Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney. Sun BK; Li C; Lim SW; Jung JY; Lee SH; Kim IS; Kim YS; Kim J; Bang BK; Yang CW J Lab Clin Med; 2004 Mar; 143(3):175-83. PubMed ID: 15007308 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of pravastatin on transforming growth factor beta1-inducible gene h3 expression in a rat model of chronic cyclosporine nephropathy. Li C; Lim SW; Choi BS; Lee SH; Cha JH; Kim IS; Kim J; Yang CW Am J Nephrol; 2005; 25(6):611-20. PubMed ID: 16308546 [TBL] [Abstract][Full Text] [Related]
4. Blockade of angiotensin II with losartan attenuates transforming growth factor-beta1 inducible gene-h3 (betaig-h3) expression in a model of chronic cyclosporine nephrotoxicity. Sun BK; Li C; Lim SW; Choi BS; Lee SH; Kim IS; Kim YS; Bang BK; Yang CW Nephron Exp Nephrol; 2005; 99(1):e9-16. PubMed ID: 15637465 [TBL] [Abstract][Full Text] [Related]
5. Influence of the renin-angiotensin system on epidermal growth factor expression in normal and cyclosporine-treated rat kidney. Yang CW; Ahn HJ; Kim WY; Shin MJ; Kim SK; Park JH; Kim YO; Kim YS; Kim J; Bang BK Kidney Int; 2001 Sep; 60(3):847-57. PubMed ID: 11532080 [TBL] [Abstract][Full Text] [Related]
6. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Zhang J; Wu Y; Jin Y; Ji F; Sinclair SH; Luo Y; Xu G; Lu L; Dai W; Yanoff M; Li W; Xu GT Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):732-42. PubMed ID: 18235022 [TBL] [Abstract][Full Text] [Related]
7. Protective effect of paricalcitol on cyclosporine-induced renal injury in rats. Piao SG; Song JC; Lim SW; Chung BH; Choi BS; Yang CW Transplant Proc; 2012 Apr; 44(3):642-5. PubMed ID: 22483459 [TBL] [Abstract][Full Text] [Related]
8. Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment. Xie Z; Wu X; Qiu Q; Gong Y; Song Y; Gu Q; Li C Curr Eye Res; 2007 Sep; 32(9):757-64. PubMed ID: 17882708 [TBL] [Abstract][Full Text] [Related]
9. The role of macrophage in the pathogenesis of chronic cyclosporine-induced nephropathy. Ghee JY; Han DH; Song HK; Kim WY; Kim SH; Yoon HE; Choi BS; Kim YS; Kim J; Yang CW Nephrol Dial Transplant; 2008 Dec; 23(12):4061-9. PubMed ID: 18622021 [TBL] [Abstract][Full Text] [Related]
10. Long-term treatment with cyclosporine decreases aquaporins and urea transporters in the rat kidney. Lim SW; Li C; Sun BK; Han KH; Kim WY; Oh YW; Lee JU; Kador PF; Knepper MA; Sands JM; Kim J; Yang CW Am J Physiol Renal Physiol; 2004 Jul; 287(1):F139-51. PubMed ID: 14871880 [TBL] [Abstract][Full Text] [Related]
11. Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy. Li C; Yang CW; Park JH; Lim SW; Sun BK; Jung JY; Kim SB; Kim YS; Kim J; Bang BK Am J Physiol Renal Physiol; 2004 Jan; 286(1):F46-57. PubMed ID: 14519596 [TBL] [Abstract][Full Text] [Related]
12. Erythropoietin enhances angiogenesis in an experimental cyclosporine A-induced nephrotoxicity model in the rat. Efthimiadou A; Pagonopoulou O; Lambropoulou M; Papadopoulos N; Nikolettos NK Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):866-9. PubMed ID: 17645631 [TBL] [Abstract][Full Text] [Related]
13. Attenuation of interstitial inflammation and fibrosis by recombinant human erythropoietin in chronic cyclosporine nephropathy. Lee SH; Li C; Lim SW; Ahn KO; Choi BS; Kim YS; Moon IS; Kim J; Bang BK; Yang CW Am J Nephrol; 2005; 25(1):64-76. PubMed ID: 15746540 [TBL] [Abstract][Full Text] [Related]
14. Erythropoietin and its non-erythropoietic derivative: do they ameliorate renal tubulointerstitial injury in ureteral obstruction? Srisawat N; Manotham K; Eiam-Ong S; Katavetin P; Praditpornsilpa K; Eiam-Ong S Int J Urol; 2008 Oct; 15(11):1011-7. PubMed ID: 18759748 [TBL] [Abstract][Full Text] [Related]
15. Antiapoptotic properties of recombinant human erythropoietin protects against tubular cyclosporine toxicity. Pallet N; Bouvier N; Legendre C; Beaune P; Thervet E; Choukroun G; Martinez F Pharmacol Res; 2010 Jan; 61(1):71-5. PubMed ID: 19766721 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of tea polyphenols on transforming growth factor-beta1 expression in rat with cyclosporine A-induced chronic nephrotoxicity. Shi SH; Zheng SS; Jia CK; Zhu YF; Xie HY Acta Pharmacol Sin; 2004 Jan; 25(1):98-103. PubMed ID: 14704129 [TBL] [Abstract][Full Text] [Related]
17. Colchicine suppresses osteopontin expression and inflammatory cell infiltration in chronic cyclosporine nephrotoxicity. Li C; Yang CW; Ahn HJ; Kim WY; Park CW; Park JH; Cha JH; Kim J; Kim YS; Bang BK Nephron; 2002 Oct; 92(2):422-30. PubMed ID: 12218323 [TBL] [Abstract][Full Text] [Related]
18. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia. Landau D; London L; Bandach I; Segev Y PLoS One; 2018; 13(5):e0196684. PubMed ID: 29738538 [TBL] [Abstract][Full Text] [Related]
20. Expression of apoptosis-related factors in chronic cyclosporine nephrotoxicity after cyclosporine withdrawal. Li C; Lim SW; Sun BK; Choi BS; GLowacka S; Cox A; Kelly D; Kim YS; Kim J; Bang BK; Yang CW Acta Pharmacol Sin; 2004 Apr; 25(4):401-11. PubMed ID: 15066204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]